Optiver Holding’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.9K Buy
1,883
+1,459
+344% +$3.02K ﹤0.01% 942
2025
Q1
$933 Buy
+424
New +$933 ﹤0.01% 1011
2024
Q4
Sell
-1,005
Closed -$2K 781
2024
Q3
$2K Sell
1,005
-800
-44% -$1.59K ﹤0.01% 542
2024
Q2
$6.32K Buy
+1,805
New +$6.32K ﹤0.01% 428